ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Falls 10.7% – What’s Next?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price fell 10.7% during mid-day trading on Tuesday. The stock traded as low as $15.96 and last traded at $15.96. Approximately 54,431 shares traded hands during trading, a decline of 76% from the average daily volume of 226,006 shares. The stock had previously closed at $17.88.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Weiss Ratings upgraded ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, October 9th. Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 price objective for the company. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $19.00.

ChronoScale Corporation Common Stock Price Performance

The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of -2.77 and a beta of 0.98. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06. The company’s 50 day moving average is $19.98 and its 200 day moving average is $18.15.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The firm had revenue of $41.48 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc raised its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent filing with the Securities and Exchange Commission. 6.42% of the stock is currently owned by institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.